Factors Influencing Discontinuation of Clazosentan Therapy in Elderly Patients with Aneurysmal Subarachnoid Hemorrhage: A Retrospective Study from a Japanese Single Center

Tatsushi Mutoh; Hiroaki Aono; Wataru Seto; Takehiro Kimoto; Ryota Tochinai; Junta Moroi; Tatsuya Ishikawa

doi:10.12659/MSM.943303

16 February 2024: Clinical Research

Factors Influencing Discontinuation of Clazosentan Therapy in Elderly Patients with Aneurysmal Subarachnoid Hemorrhage: A Retrospective Study from a Japanese Single Center

Tatsushi Mutoh ^1ABCDEF* , Hiroaki Aono ^1BDE , Wataru Seto ^2BE , Takehiro Kimoto ^2BE , Ryota Tochinai ^3DE , Junta Moroi ^1BE , Tatsuya Ishikawa ^1DE

DOI: 10.12659/MSM.943303

Med Sci Monit 2024; 30:e943303

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

View HTML version

Figure 2 ROC analysis of day-to-day urine volume variations in 40 postoperative SAH patients to predict the ability of clazosentan discontinuation (obtained from Prism version 9.5.1, GraphPad Software, USA). ROC – Receiver operating characteristic curve; SAH – subarachnoid hemorrhage.

Back to the Article

Factors Influencing Discontinuation of Clazosentan Therapy in Elderly Patients with Aneurysmal Subarachnoid Hemorrhage: A Retrospective Study from a Japanese Single Center

Your Privacy